|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 76.99 USD | +0.03% |
|
+0.09% | +182.32% |
| 08-27 | Argenx SE completed the acquisition of Forte Biosciences, Inc.. | CI |
| 08-27 | Argenx Completes Acquisition of Forte Biosciences | MT |
Chart calendar Forte Biosciences
e56ac5712cd68752df61abdaa13697ff.X3cKNuaLhv8x3ja8vsdRQQDuqbXn2ayzltw0mG7rLio.GSZpQr-5x5oGk3TaxrUbFEyc5MSfrs_31I5f3gqKeFk7JWlTq-rWil-yZw~878ff20faa758b3c14012e43dee47576
Upcoming events on Forte Biosciences
No events available
Past events on Forte Biosciences
| 09/07/2026 | Information meeting | 15:30 |
| 29/05/2026 | Présentation aux Actionnaires / Analystes | 16:00 |
| 29/05/2026 | Annual General Meeting | 16:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -36,6 -38,2 4.19% | -70,7 -66,3 -6.62% | -91,1 | -107 | -128 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -35,5 -37,2 4.51% | -68,3 -64,7 -5.69% | -91,1 | -107 | -128 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -35,5 -37,2 4.51% | -69,4 -64,7 -7.3% | -91,1 | -107 | -128 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -12,2 -6,73 -80.83% | -4,71 -4,31 -9.22% | -4,48 | -4,08 | -4,17 |
| Announcement Date | 18/03/24 | 28/03/25 | 31/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,35 -8,95 17.87% | -16,1 -7,63 -111.41% | -11,6 -13,4 13.55% | -18,4 -12,5 -47.37% | -24,6 -18,9 -29.74% | -22,4 -20,6 -8.75% | -24,6 -22,7 -8.56% | -22,9 | -23,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,16 -8,83 18.98% | -17,7 -12,3 -43.76% | -23,8 -18,4 -29.13% | -21,8 -18,2 -19.37% | -23,1 -22,7 -2.1% | -22,9 | -23,1 | ||
|
Net income Million USD | Released Forecast Spread | -7,16 -8,83 18.98% | -11,2 -10,0 -12.49% | -17,7 -12,3 -43.76% | -24,8 -18,4 -34.77% | -22,1 -18,2 -21.42% | -23,3 -22,7 -2.95% | -22,9 | -23,1 | |
|
EPS USD | Released Forecast Spread | -1,76 | -1,37 -0,95 -44.21% | -0,96 -1,00 3.68% | -0,99 -1,03 3.57% | -1,45 -1,22 -18.85% | -1,24 -1,19 -4.49% | -0,97 -1,00 3.32% | -1,09 | -1,11 |
| Announcement Date | 28/03/25 | 15/05/25 | 14/08/25 | 14/11/25 | 31/03/26 | 11/05/26 | 12/08/26 | - | - |
Past sector events for Forte Biosciences
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- FBRX Stock
- Calendar Forte Biosciences
Select your edition
All financial news and data tailored to specific country editions
